Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / S•••••• P•••••

TVM L••• S•••••• Innovation II SCSp Announces Investment in S•••••• P•••••, Inc.

Platform acquisitionannouncedannounced Feb 1, 2021Fact
What happened
Target
S•••••• P•••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / pharma
Target location
DE, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
Side not stated
  • C••••••• F••••••Managementconfirmed
    “Auto-immune diseases, namely lupus, remain a significant unmet clinical need that needs to be addressed,” said C••••••• F••••••, CEO of S•••••• P•••••, Inc.”
  • S•••••• P•••••Targetconfirmed
    “TVM L••• S•••••• Innovation II SCSp Announces Investment in S•••••• P•••••, Inc.”
Evidence
“TVM L••• S•••••• Innovation II SCSp Announces Investment in S•••••• P•••••, Inc.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 17, 2026
TVM L••• S•••••• Innovation II SCSp Announces Investment in S•••••• P•••••, Inc. | Private Equity Intelligence | DFX